Pfizer Animal Health new generation/technology PRRS vaccine is now registered in Canada

Registered for use in young pigs, Fostera PRRS helps growing pigs defend against a PRRSV challenge, allowing them to increase their post challenge weight gain compared to non-vaccinates groups.

Wednesday 2 May 2012 (6 years 5 months 13 days ago)
Like

Pfizer Animal HealthFosteraTM PRRS vaccine is now registered for use in Canada by Pfizer Animal Health as an aid in preventing disease associated with Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), Respiratory Form, a disease that costs Canada’s pork industry an estimated $130 million annually.

Fostera PRRS is a modified live vaccine for the vaccination of healthy, susceptible swine three weeks of age, or older, in PRRSV-positive herds or seronegative pigs deemed at risk for exposure to PRRSV, as an aid in preventing respiratory disease associated with PRRSV.

“PRRSV is endemic in almost all pork-producing areas of the world,” says Walter Heuser, DVM, Swine Business Unit Director for Pfizer Animal Health. “This new modified live vaccine option will help protect growing pigs facing a PRRSV challenge, and assist the Canadian swine industry in the management of this costly disease.”

Registered for use in young pigs, Fostera PRRS helps growing pigs defend against a PRRSV challenge, allowing them to increase their post challenge weight gain compared to non-vaccinates groups. Fostera PRRS is available exclusively through Canadian veterinarians.

May 1, 2012 - Pfizer Animal Health

Article Comments

This area is not intended to be a place to consult authors about their articles, but rather a place for open discussion among pig333.com users.
Leave a new Comment

Access restricted to 333 users. In order to post a comment you must be logged in.

Not a registered user of 333?sign upand access swine prices, the search engine, ...
It is fast and free
Are you registered in 333?LOGINIf you've forgotten your password we'll send it to you here

tags